Study design and statistical analysis: A practical guide for clinicians

Study Design and Statistical Analysis: A Practical Guide for Clinicians

Volumn , Issue , 2006, Pages 1-188

  Katz, Mitchell H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924447816     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511616761     Document Type: Book

References (159)

1. van Walraven, C., Hart, R.G., Singer, D.E., et al. Oral anticoagulants versus aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. J. Am.Med. Assoc.2002; 288: 2441–8.
2. Ponsky, T.A., Huang, Z.J., Kittle, K., et al. Hospital- and patient-level characteristics and the risk of appendiceal rupture and negative appendectomy in children. J. Am.Med. Assoc.2004; 292: 1977–82.
3. Braveman, P., Schaaf, V.M., Egerter, S., Bennett, T., Schecter, W. Insurance-related differences in the risk of ruptured appendix.New Engl. J. Med. 1994; 331: 444–9.
4. Ioannidis, J.P. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. J. Am.Med. Assoc.1998; 279: 281–6.
5. Katz, M.H., Hessol, N.A., Buchbinder, S.P., et al. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J. Infect. Dis.1994; 170: 198–202.
6. Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., Newman, T.B. Designing Clinical Research(2nd edition). Philadelphia: Lippincott Williams & Wilkins, 2001, pp. 17–24.
7. Verghese, J., Lipton, R.B., Katz, M.J., et al. Leisure activities and the risk of dementia in the elderly. New Engl. J. Med.2003; 348: 2508–16.
8. Ball, K., Berch, D.B., Helmers, K.F., et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. J. Am.Med. Assoc.2002; 288: 2271–81.
9. Horng, S., Miller, F.G. Is placebo surgery unethical? New Engl. J. Med. 2002; 347: 137–9.
10. Ioannidis, J.P.A., Haidich, A-B., Pappa, M., et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. J. Am.Med. Assoc.2001; 286: 821–30.
11. Grodstein, F., Clarkson, T.B., Manson, J.E. Understanding the divergent data on postmenopausal hormone therapy.New Engl. J. Med. 2003; 348; 645–50.
12. Karst, M. Salim, K., Burstein, S., et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain. J. Am.Med. Assoc.2003; 290: 1757–62.
13. The Steering Committee of the Physicians’Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study.New Engl. J. Med. 1989; 321: 129–35.
14. Hennekens, C.H., Buring, J.E., Manson, J.E., et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease.New Engl. J. Med. 1996; 334: 1145–9.
15. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians (2nd edition). Cambridge: Cambridge University Press, 2005; pp. 11–13, 98–101, 134, 143–5.
16. Morris, C.D., Carson, S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the US Preventive Services Task Force. Ann. Intern.Med.2003; 139: 56–70.
17. Friedman, L.M., Furberg, C.D., DeMets, D.L. Fundamentals of Clinical Trials(3rd edition). New York, Springer, 1999.
18. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volumereduction surgery with medical therapy for severe emphysema.New Engl. J. Med. 2003; 348: 2059–73.
19. Gallant, J.E., Staszewski, S., Pozniak, A.L., et al. Efficacy and safety of tenofovir df vs stavudine in combination therapy in antiretroviral-naïve patients. J. Am.Med. Assoc.2004; 292: 191–201.
20. Turner, C.F., Rogers, S.M., Milleer, H.G., et al. Untreated gonococcal and chlamydial infection in a probability sample of adults. J. Am.Med. Assoc.2002; 287: 726–33.
21. Ernster, V.L., Grady, D., Miike, R., et al. Facial wrinkling in men and women, by smoking status. Am. J. Public Health1995; 85: 78–82.
22. Forsyth, B.W., Horwitz, R.I., Acampora, D., et al. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye’s syndrome association. J. Am.Med. Assoc.1989; 261: 2517–24.
23. Rothman, K.J., Greenland, S.Modern Epidemiology(2nd edition). Philadelphia, PA: Lippincott Williams & Wilkins, 1998, pp. 147–61.
24. Kelsey, J.L., Whittemore, A.S., Evans, A.S., Thompson, W.D.Methods in Observational Epidemiology(2nd edition). Oxford: Oxford University Press, 1996, pp. 214–39.
25. Szklo, M., Nieto, F.J. Epidemiology: Beyond the Basics. Gaithersburg, Maryland: Aspen Publication, pp. 40–8.
26. Meier, C.R., Derby, L.E., Jick, S.S., Vasiolakis, C., Jick, H. Antibiotics and risk of subsequent first-time acute myocardial infarction. J. Am.Med. Assoc.1999; 281: 427–31.
27. Cohen, D.A., Mason, K., Bedimo, A., et al. Neighborhood physical conditions and health. Am. J. Public Health 2003; 93: 467–71.
28. King, G. A Solution to the Ecological Inference Problem. Princeton: Princeton University Press, 1997.
29. Hodnet, E.D., Lowe, N.K., Hannah, M.E., et al. Effectiveness of nurses as providers of birth labor support in North American hospitals. J. Am.Med. Assoc.2002; 288: 1373–81.
30. Lange, H., Suryapranata, H., De Luca, G., et al. Folate therapy and in-stent restenosis after coronary stenting.New Engl. J. Med. 2004; 350: 2673–81.
31. Schnyder, G., Roffi, M., Pin, R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.New Engl. J. Med. 2001; 345: 1593–600.
32. Frankel, M.R., Shapiro, M.F., Duan, N., et al. National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization sample. Health Serv. Res. 1999; 34: 969–92.
33. Rozovsky, R.A., Adams, R.K. Clinical Trials and Human Research: A Practical Guide to Regulatory Compliance. San Francisco, CA: Jossey-Bass, 2003.
34. Friedman, L.M., Furberg, C.D., DeMets, D.L. Fundamentals of Clinical Trials(3rd edition). New York: Springer, 1999.
35. Kelsey, J.L., Whittemore, A.S., Evans, A.S., Thompson, W.D.Methods in Observational Epidemiology (2nd edition). Oxford: Oxford University Press, 1996, pp. 364–412.
36. Kissinger, P., Rice, J., Farley, T., et al. Application of computer-assisted interviews to sexual behaviour research. Am. J. Epidemiol.1999; 149: 950–4.
37. Bennett, S., Myatt, M., Jolley, D., Radalowicz, A. Data Management for Surveys and Trials Denmark: EpiData Association, 2001, available free at http://www.gnu.org/copyleft/fdl.html.
38. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians(2nd edition). Cambridge: Cambridge University Press, 2005, 85–6.
39. Maisel, A.S., Krishnaswamy, P., Nowak, R.M. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.New Engl. J. Med. 2002; 347: 161–7.
40. Pai, M., Gokhale, K., Joshi, R., et al.Mycobacterium tuberculosis infection in health care workers in rural India. J. Am.Med. Assoc.2005; 293: 2746–55.
41. Vittinghoff, E., Glidden, D.V., Shiboski, S.C., McCulloch, C.E. Regression Methods in Biostatistics. New York: Springer, 2005, p. 13.
42. Fletcher, R.H., Fletcher, S.W., Wagner, EH. Clinical Epidemiology: The Essential (3rd edition). pp. 767, 79–80.
43. Eisenberg, D.M., Kessler, R.C., Van Rompay, M.I., et al. Perceptions about complimentary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann.Intern. Med.2001; 135: 344–51.
44. Kyrle, P.A., Minar, E., Hirschl, M., et al. High plasma levels of factor VII and the risk of recurrent venous thromboembolism.New Engl. J. Med. 2000; 343: 457–62.
45. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians (2nd edition). Cambridge: Cambridge University Press, 2005, pp. 29–32, 56–67.
46. Soteriades, E.S., Evans, J.C., Larson, M.G., et al. Incidence and prognosis of syncope. New Engl. J.Med.2002; 347: 878–85.
47. Kahn, H.A. Sempos, C.T. Statistical Methods in Epidemiology. Oxford: Oxford University Press, 1989, pp. 168–224.
48. Glantz, S.A. Primer of Biostatistics(5th edition). New York:McGraw-Hill, 2002.
49. Fleiss, J.L., Levin, B., Paik, M.C. Statistical Methods for Rates and Proportions(3rd edition). Hoboken, New Jersey:Wiley & Sons, 2003.
50. Villar, R.G., Shapiro, R.L., Busto, S. Outbreak of Type A botulism and development of a botulism surveillance and antitoxin release system in Argentina. J. Am.Med. Assoc.1999; 281: 1334–8, 1340.
51. Ebrahim, S.H., Floyd, R.L., Merritt, R.K., Decoufle, P., Holtzman, D. Trends in pregnancy-related smoking rates in the United States, 1987–1996. J. Am.Med. Assoc. 2000; 283: 361–6.
52. Saposnik, G., Young, B., Silver, B., et al. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy. J. Am.Med. Assoc.2004; 292: 1839–44.
53. Karter, A.J., Ferrara, A., Liu, J.Y., Moffet, H.H., Ackerson, L.M., Selby, J.V. Ethnic disparities in diabetic complications in an insured population. J. Am.Med. Assoc. 2002; 287: 2519–27.
54. Glantz, S.A., Slinker, B.K. Primer of Applied Regression and Analysis of Variance. New York:McGraw-Hill, pp. 125–77.
55. Rosner, B.Fundamentals of Biostatistics(5th edition). Pacific Grove: Duxbury, 2000, pp. 174–6.
56. Vittinghoff, E., Glidden, D.V., Shiboski, S.C., McCulloch, C.E. Regression Methods in Biostatistics. New York: Springer, 2005, pp. 33–5, 119.
57. Vitovski, S., Dunkin, K.T., Howard, A.J., Sayers, J.R. Nontypeable Haemophilus influenzae in carriage and disease: a difference in IgA1 protease activity levels. J. Am.Med. Assoc.2002; 287: 1699–705.
58. Glantz, S.A., Slinker, B.K. Primer of Applied Regression and Analysis of Variance. New York:McGraw-Hill, pp. 308–9.
59. Glantz, S.A. Primer of Biostatistics(5th edition). New York:McGraw-Hill, 2002, pp. 200–9.
60. Samaha, F.F., Iqbal, N., Seshadri, P. et al. A low-carbohydrate as compared with a low-fat diet in severe obesity.New Engl. J. Med. 2003; 348: 2074–81.
61. Motulsky H. Intuitive Biostatistics. Oxford: Oxford University Press, 1995, pp. 221–4.
62. Glantz, S.A. Primer of Biostatistics (5th edition). New York:McGraw-Hill, 2002, pp. 89–107.
63. Motulsky H. Intuitive Biostatistics. Oxford: Oxford University Press, 1995, pp. 259.
64. Glantz, S.A. Primer of Biostatistics(5th edition). New York:McGraw-Hill, 2002, p. 366.
65. Buffon, A., Biasucci, L.M., Liuzzo, G., et al.Widespread coronary inflammation in unstable angina. New Engl. J. Med.2002; 347: 5–12.
66. Uren, N.G., Melin, J.A., De Bruyne, B., Wijns, W., Baudhuin, T., Camici, P.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis.New Engl. J. Med. 1994; 330: 1782–8.
67. Glynn, R.J., Beckett, L.A., Hebert, L.E., Morris, M.C., Scherr, P.A., Evans, D.A. Current and remote blood pressure and cognitive decline. J. Am.Med. Assoc. 1999; 281: 438–45.
68. Canfield, R.L., Hendeerson, C.R., Cory-Slechta, D.A., Cox, C., Jusko, T.A., Lanphear, B.P. Intellectual impairment in children with blood lead concentrations below 10_g per deciliter.New Engl. J. Med. 2003; 348: 1517–26.
69. Harrell, F.E. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression and Survival Analysis. New York: Springer-Verlag, 2001, pp. 18–24.
70. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians (2nd edition). Cambridge University Press, 2005, 46–51.
71. Ahlborg, H.G., Johnell, O., Turner, C.H., et al. Bone loss and bone size after menopause. New Engl. J.Med.2003; 349: 327–34.
72. Schillinger, D., Grumbach, K., Piette, J., et al. Association of health literacy with diabetes outcomes. J. Am.Med. Assoc.2002; 288: 475–82.
73. Landefeld, C.S., Palmer, R.M., Kresevic, D.M., Fortinsky, R.H., Kowal, J. A randomized trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients. New Engl. J.Med.1995; 332: 1338–44.
74. Rao, S.V., Jollis, J.G., Harrington, R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. J. Am.Med. Assoc.2004; 292: 1555–62.
75. McFalls, E.O., Ward, H.B., Moritz, T.E., et al. Coronary-artery revascularization before elective major vascular surgery.New Engl. J. Med. 2004; 351: 2795–804.
76. Erbel, R., Haude, M., Hopp, H.W., et al. Coronary-artery stenting compared with balloon angioplasty for restensosis after initial balloon angioplasty.New Engl. J. Med. 1998; 339: 1672–8.
77. Laheij, R.J.F., Sturkenboom, M.C.J.M., Hassing, R., Dieleman, J., Stricker, B.H.C., Jansen, J.B.M.J. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. J. Am.Med. Assoc. 2004; 292: 1955–60.
78. Rosner, B. Fundamentals of Biostatistics(5th edition). California: Duxbury, 2000, pp. 684–5.
79. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians (2nd edition). Cambridge University Press, 2005, pp. 158–78.
80. Kuipers, E.J., Lundell, L., Klinkenberg-Knol, E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. New Engl. J. Med.1996; 334: 1018–22.
81. Fleiss, J.L., Levin, B., Paik, M.C. Statistical Methods for Rates and Proportions(3rd edition). Hoboken, New Jersey:Wiley & Sons, 2003, pp. 126–33.
82. Buchbinder, S.P., Douglas, J.M., McKirnan, D.J., et al. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J. Infect. Dis. 1996: 174: 954–61.
83. Moliterno, D.J., Willard, J.E., Lange, R.A., et al. Coronary artery vasoconstriction induced by cocaine, cigarette smoking, or both.New Engl. J. Med. 1994; 330: 454–9.
84. Tate, D.F., Wing, R.R., Winett, R.A. Using internet technology to deliver a behavioral weight loss program. J. Am.Med. Assoc.2001; 285: 1172–7.
85. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians (2nd edition). Cambridge University Press, 2005, Chapter 12.
86. Davi, G., Guagnana, M.T., Ciabattoni, G., et al. Platelet activation in obese women: role of inflammation and oxidant stress. J. Am.Med. Assoc.2002; 288: 2008–14.
87. Herrstedt, J., Sigsgaard, T., Boesgaard, M., Jensen, T.P., Dombernowsky, P. Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.New Engl. J. Med. 1993; 328: 1076–80.
88. Darzins, R., Molloy, D.W., Harrison, C. Treatment for life-threatening illness.New Engl. J. Med. 1993; 329: 736.
89. Kujala, U.M., Kaprio, J., Koskenvuo, M.Modifiable risk factors as predictors of all-cause mortality: the roles of genetics and childhood environment. Am. J. Epidemiol.2002; 156: 985–93.
90. Mathur, R., Douglas, N.J. Family studies in patients with the sleep apnea–hypopnea syndrome. Ann. Intern. Med.1995; 122: 174–8.
91. Katz, M.H. Multivariable analysis: a primer for readers of medical research. Ann. Intern.Med. 2003; 138: 644–50.
92. Hujoel, P.P., Drangsholt, M., Spiekerman, C., DeRouen, T.A. Periodontal disease and coronary heart disease risk. J. Am.Med. Assoc.2000; 284: 1406–10.
93. Harrell, F.E. Regression Modeling Strategies. New York: Springer, 2001, p. 4.
94. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians(2nd edition). New York: Cambridge University Press, 2005.
95. Scott, S.C., Goldberg, M.S., Mayo, N.E. Statistical assessment of ordinal outcomes in comparative studies. J. Clin. Epidemiol. 1997; 50: 45–55.
96. Menard, S. Applied Logistic Regression Analysis. Thousand Oaks, CA: Sage Publications, 1995, pp. 80–90.
97. Feinstein, A.R.Multivariable Analysis: An Introduction. New Haven: Yale University Press, 1996, pp. 431–74.
98. Spruance, S.L., Reid, J.E., Grace, M., Samore, M. Hazard ratio in clinical trials. Antimicrob. Agents Chemother.2004; 48: 2787–92.
99. O’Malley, P.G., Jones, D.L., Feuerstein, I.M., Taylor, A.J. Lack of correlation between psychological factors and subclinical coronary artery disease.New. Engl. J. Med. 2000; 343: 1298–1304.
100. Harrell, F.E. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag, 2001, pp. 18–24.
101. Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., Newman, T.B.Designing Clinical Research(2nd edition). Philadelphia, PA: Lippincott Williams & Wilkins, 2001, pp. 65–91.
102. Friedman, L.M., Furberg, C.D., DeMets, D.L. Fundamentals of Clinical Trials(3rd edition).New York: Springer, 1999, pp. 94–129.
103. Man-Son-Hing, M., Laupacis, A., O’Rourke, K., et al. Determination of the clinical importance of study results. J. Gen. Int.Med.2002; 17: 469–76.
104. Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., Newman, T.B. Designing Clinical Research(2nd edition). Philadelphia, PA: Lippincott Williams & Wilkins, 2001, pp. 78–9.
105. Raine, T.T., Harper, C.C., Rocca, C.H., et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs. J. Am.Med. Assoc.2005; 293: 54–62.
106. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians(2nd edition). New York: Cambridge University Press, 2005, pp. 77–81.
107. Ware, J.H., Antman, E.M. Equivalence trials.New Engl. J. Med. 1997; 337: 1159–61.
108. Parienti, J-J. “Tenofovir, equivalence, and noninferiority [letter].” J. Am.Med. Assoc.2004; 292: 1951.
109. Gallant, J.E., Staszewski, S., Pozniak, A.L., et al. “In Reply to tenofovir, equivalence, and noninferiority [letter]”. J. Am.Med. Assoc.2004; 292: 1951.
110. Columbus Investigators. “Low-molecular-weight heparin in the treatment of patients with venous thromboembolism”.New Engl. J. Med. 1992; 337: 657–62.
111. Reilly, B.M., Evans, A.T., Schaider, J.J., et al. Impact of a clinical decision rule on hospital triage of patients with suspected acute cardiac ischemia in the emergency department. J. Am.Med. Assoc. 2002; 288: 342–50 (data reported are from the intervention group).
112. Elliott, W.J., Powell, L.H. Diagonal earlobe creases and prognosis in patients with suspected coronary artery disease.Am. J. Med. 1996; 100: 205–11.
113. Stiell, I.G., Greenberg, G.H., McKnight, R.D., et al. Decision rules for the use of radiography in acute ankle injuries. J. Am.Med. Assoc. 1993; 269: 1127–32.
114. Fletcher, R.H., Fletcher, S.W., Wagner, E.H. Clinical Epidemiology: The Essentials. (3rd edition). pp. 48–60.
115. Cleary, P.D., Barry, M.J., Mayer, K.H., et al. Compulsory premarital screening for the human immunodeficiency virus. J. Am.Med. Assoc.1987; 258: 1757–62.
116. Reilly, B.M., Evans, A.T., Schaider, J.J., et al. Impact of a clinical decision rule on hospital triage of patients with suspected acute cardiac ischemia in the emergency department. J. Am.Med. Assoc. 2002; 288: 342–50 (reported data are from the intervention group).
117. Hoffman, R.M., Gilliland, F.D., Adams-Cameron, M., et al. Prostate-specific antigen testing accuracy in community practice. BMC Fam. Prac.2002; 3: 19 (http://www.biomedcentral.com/1471-2296/3/19).
118. Hanley, J.A., McNeil, B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology1982; 143: 29–36.
119. Hsiao, J.K., Bartko, J.J., Potter, W.Z. Diagnosing diagnoses: receiver operating characteristic methods and psychiatry. Arch. Gen. Psychiat.1989; 46: 664–7.
120. USPSTF. Screening for prostate cancer: recommendation and rationale. Ann. Int.Med.2002; 137: 915–16.
121. Fletcher, R.H., Fletcher, S.W., Wagner, E.H. Clinical Epidemiology: The Essentials (3rd edition). Philadelphia: Lippincott Williams & Wilkins, 1996, p. 43.
122. Rothman, R., Owens, T., Simel, D.L. Does this child have acute otitis media? J. Am.Med. Assoc.2003; 290: 1633–40.
123. Karma, P.H., Penttila, M.A., Sipila, M.M., et al. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media: I. the value of different otoscopic findings. Int. J. Pediatr. Otorhinolaryngol. 1989; 17: 37–49.
124. Qanadli, S.D., Hajjam, M.E., Mesurolle, B., et al. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000; 217: 447–55.
125. Van Strijen, M.J.L., de Monye, W., Schiereck, J., et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann. Intern.Med.2003; 138: 307–14.
126. Whiting, P., Rutjes, A.W.S., Reitsma, J.B., et al. Sources of variation and bias in studies of diagnostic accuracy. Ann. Intern.Med. 2004; 140: 189–202.
127. Fletcher, R.H., Fletcher, S.W., Wagner, E.H. Clinical Epidemiology: The Essentials (3rd edition). pp. 54–5.
128. Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., Newman, T.B. Designing Clinical Research(2nd edition). Philadelphia: Lippincott Williams & Wilkins. 2001, pp. 179–80.
129. Katz, M.H.Multivariable Analysis: A Practical Guide for Clinicians(2nd edition). Cambridge: Cambridge University Press, 2005, pp. 179–83.
130. Hill, A.G. The environment and disease: association or causation? Proc. Roy. Soc.Med. 1965; 58: 295–300.
131. Habu, D., Shiomi, S., Tamori, A., et al. Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver. J. Am.Med. Assoc.2004; 292: 358–61.
132. Lam, T.H., Ho, L.M., Hedley, A.J. Environmental tobacco smoke exposure among police officers in Hong Kong. J. Am.Med. Assoc.2000; 284: 756–63.
133. Vittinghoff, E., Glidden, D.V., Shiboski, S.C., McCulloch, C.E. Regression Methods in Biostatistics. New York: Springer, 2005, pp. 82–3.
134. Taubes, G. Epidemiology faces its limits. Science1995; 269: 164–9.
135. Thun, M.J., Apicella, L.F., Henley, S.J. Smoking vs other risk factors as the cause of smokingattributable deaths. J. Am.Med. Assoc.2000; 284: 706–12.
136. Katz, M.H., Cunningham, W.E., Fleishman, J.A., et al. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. Ann. Int.Med. 2001; 135: 557–65.
137. Szklo, M., Nieto, F.J. Epidemiology: Beyond the Basics. Gaithersburg, Maryland: Aspen Publication, pp. 125–76.
138. Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., Newman, T.B. Designing Clinical Research(2nd edition). Philadelphia: Lippincott Williams & Wilkins, 2001, pp. 126–8.
139. Tang, M.-X., Jacobs, D., Stern, Y., et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet1996; 348: 429–32.
140. Baldereschi, M., De Carlo, A., Lepore, V., et al. Estrogen-replacement therapy and Alzheimer’s disease in the Italian longitudinal study on aging. Neurology1998; 50: 996–1002.
141. Zandi, P.P., Carlson, M.C., Plassman, B.L., et al. Hormone replacement therapy and incidence of Alzheimer disease in older women. J. Am.Med. Assoc.2002; 288: 2123–9.
142. Paganini-Hill, A., Henderson, V.W. Estrogen deficiency and risk of Alzheimer’s disease in women. Am. J. Epidemiol.1994; 140: 256–61.
143. Kawas, C., Resnick, S., Morrison, A., et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: The Baltimore Longitudinal Study of Aging. Neurology1997; 48: 1517–21.
144. Yaffe, K.Hormone therapy and the Brain: Déjà vu all over again? J. Am.Med. Assoc.2003; 289: 2717–18.
145. Shumaker, S.A., Legault, C., Rapp, S.R., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. J. Am.Med. Assoc.2003; 289: 2651–62.
146. Flum, D.R., Dellinger, E.P., Cheadle, A., Chan, L., Koepsell, T. Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy. J. Am.Med. Assoc.2003; 289: 1639–44.
147. Qizilbash, N., Birks, J., Lopez Arrieta, J., Lewington S., Szeto, S. Tacrine for Alzheimer’s disease (Cochrane Review). In: The Cochrane Library (Issue 3). 2003, Oxford: Update Software.
148. Man-Son-Hing, M., Laupacis, A., O’Rourke, K., et al. Determination of the clinical importance of study results. J. Gen. Int.Med.2002; 17: 469–76.
149. Kadish, A., Dyer, A., Daubert, J.P., et al. Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. New Engl. J. Med.2004; 350: 2151–8.
150. Shaheen, N., Ransohoff, D.F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer. J. Am.Med. Assoc.2002; 287: 1972–81.
151. Rothman, K.J., Greenland, S.Modern Epidemiology(2nd edition). Philadelphia: Lippincott, Williams & Wilkins, 1998, pp. 12–14.
152. Kelsey, J.L., Whittemore, A.S., Evans, A.S., Douglas Thompson, W.Methods in Observational Epidemiology(2nd edition). Oxford: Oxford University Press, 1996, pp. 37–40.
153. Szklo, M., Nieto, F.J. Epidemiology: Beyond the Basics. Gaithersburg, Maryland: Aspen Publication, pp. 101–5.
154. Hyman, D.J., Pavlik, V.N. Characteristics of patients with uncontrolled hypertension in the United States.New Engl. J. Med.2001; 345: 479–86.
155. Kumana, C.R., Cheung, B.M.Y., Lauder, I.J. Gauging the impact of statins using number needed to treat. J. Am.Med. Assoc.1999; 282: 1899–901.
156. Owens, J.R., Clearfield, M., Weis, S. et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. J. Am.Med. Assoc.1998; 279: 1615–28.
157. Simple Interactive Statistical Analysis at http://home.clar.net/sisa/sampshlp.htm.
158. Stamm, K., Williams, J.W., Noel, P.H., Rubin R.Helping journalists get it right: a physician’s guide to improving health care reporting. J. Gen.Intern. Med. 2003; 18: 138–45.
159. Samet, J.M. Dear Author – advice from a retiring editor. Am. J. Epidemiol.1999; 150: 433–6.